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Abstract
Background: Molecular tools for detection of low-density asymptomatic Plasmodium infections are needed in
malaria elimination efforts. This study reports results from the hitherto largest implementation of loop-mediated
isothermal amplification (LAMP) for centralized mass screening of asymptomatic malaria in Zanzibar.
Methods: Healthy individuals present and willing to participate in randomly selected households in 60 villages
throughout Zanzibar were screened for malaria by rapid diagnostic tests (RDT). In 50 % of the study households,
participants were asked to provide 60 μL of finger-prick blood for additional LAMP screening. LAMP was conducted
in two centralized laboratories in Zanzibar, by trained technicians with limited or no previous experience of molecular
methods. The LAMP assay was performed with LoopampTM MALARIA Pan/Pf Detection Kit (Eiken Chemical Company,
Japan). Samples positive for Plasmodium genus (Pan)-LAMP were re-tested using Plasmodium falciparum-specific LAMP kits.
Results: Paired RDT and LAMP samples were available from 3983 individuals. The prevalence of asymptomatic malaria was
0.5 % (CI 95 % 0.1-0.8) and 1.6 % (CI 95 % 1.1-2.2) by RDT and Pan-LAMP, respectively. LAMP detected 3.4 (CI 95 % 2.2-5.2)
times more Plasmodium positive samples than RDT. DNA contamination was experienced, but solved by repetitive
decontamination of all equipment and reagents.
Conclusions: LAMP is a simple and sensitive molecular tool, and has potential in active surveillance and mass-screening
programmes for detection of low-density asymptomatic malaria in pre-elimination settings. However, in order to deploy
LAMP more effectively in field settings, protocols may need to be adapted for processing larger numbers of samples.
A higher throughput, affordable closed system would be ideal to avoid contamination.
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Background
Asymptomatic Plasmodium infections are an important
reservoir for continued malaria transmission that needs
to be addressed in the context of malaria elimination [1].
Detection of asymptomatic infections, which are often
sub-patent, i.e., fall beneath the threshold of detection of
both microscopy and rapid diagnostic tests (RDT),
requires highly sensitive molecular tools. The use of
polymerase chain reaction (PCR)-based assays in field
settings is, however, limited due to the need for a cold
chain, specialized equipment and know-how [2]. Loop-
mediated isothermal amplification (LAMP) offers several
advantages over PCR in field settings. LAMP requires
minimal equipment, has short time-to-result (30 min-1 h),
with an analytical sensitivity similar to PCR, and results
that can be read by eye using UV fluorescence [3–5].
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The Loopamp™ MALARIA Pan/Pf Detection Kit (Eiken
Chemical Company, Japan) has been developed as a
field-friendly kit, comprising strips of reaction tubes
containing vacuum-dried and temperature-stable reaction
components for either Plasmodium genus (Pan)-specific
or Plasmodium falciparum-specific malaria detection. The
kit has been evaluated both in laboratory and field settings
[6–8], and was piloted on a small scale in Zanzibar as a
health facility-based, point-of-care, diagnostic tool for
mass screening and treatment in 2013 [9].
This study reports results from the hitherto largest
implementation of LAMP in the field, for scaled-up,
centralized mass screening of asymptomatic malaria in
Zanzibar, a pre-elimination setting.
Methods
Study sites and study design
Zanzibar, located 35 km off the coast of mainland
Tanzania, consists of two main islands, Unguja and
Pemba, with respective populations of approximately
900,000 and 400,000. This study was performed as part of
a larger knowledge, attitude, practice, and behaviour
(KAPB) malaria survey, conducted in Zanzibar April-May
2014. Household visits were carried out in 60 villages in
ten districts (six in Unguja and four in Pemba) covering
the whole of Zanzibar. A proportional number of house-
holds were sampled from each village to reach a sample
size of 2162 households, powered for the KAPB study.
Healthy individuals present and willing to participate in
the randomly selected households were screened for
malaria by RDT. In 50 % of study households (in even
house numbers), participants were asked to provide 60 μL
of finger-prick blood for additional LAMP screening.
Nexus seven tablet computers were used to conduct ques-
tionnaires as part of the KAPB survey. All participants or
guardians provided written informed consent prior to blood
sampling. Ethical approvals were obtained from the ethical
committees in Zanzibar (ZAMREC/0002/FEBRUARY/014)
and the Regional Ethics Committee in Stockholm (2009/
387-31).
Training of field enumerators and sample collection
Household visits were conducted by 40 field enumerators
in teams of two, together with four field supervisors with
prior experience of similar studies. All enumerators
attended five days of training for RDT performance, blood
sample collection for LAMP, and use of tablet computers.
There were 14 teams in Unguja and six teams in Pemba,
and each team visited six or seven households per day.
RDT screening was conducted with either SD-Bioline
Malaria Ag P.f/PanW (Standard Diagnostic, Inc, USA)
(used for >90 % of screening) or First ResponseW Malaria
Ag Combo (pLDH/HRP2) (Premier Medical Corporation
Limited India). Results were recorded on the tablet
computer during household visits, and RDT positive indi-
viduals were referred to the closest health facility for treat-
ment and registration in the Zanzibar malaria surveillance
system. In 50 % of study households, 60 μL of finger-prick
blood was collected using a plastic capillary tube (Dropstir,
Medical Precision Plastics, USA), dispensed into a 1.5-ml
pre-labelled sample collection tube containing 60 μL of
pre-aliquoted DNA extraction buffer (400 nM NaCl,
40 mM Tris pH 6.5, 0.45 SDS), and mixed by flicking.
Blood samples were collected in microtube storage racks
with lids and transported at the end of each day to two
centralized laboratories, one on each island, where they
were stored at 4 °C overnight.
Training of laboratory technicians
Four technicians, two for each laboratory, with limited
or no experience of LAMP were trained over three-and-
a-half days. Training included a theoretical introduction
to LAMP and the LAMP protocol, hands-on practical
sessions with malaria positive blood samples diluted to
different known concentrations, how to record results
on tablet computers, and a half-day field trial with sam-
ples collected the same day by the field enumerators.
Screening by LAMP in centralized laboratories
LAMP procedures were similar to the pilot study [9], with
some modifications for scale-up of sample sizes. One cen-
trifuge, three heat-blocks (1.5-ml block at 95 °C, 0.2-ml
block at 65 °C and a 0.2-ml block at 95 °C) and a UV lamp
were required in each laboratory. All samples collected in
Pemba and half of the samples collected in Unguja (see
below) were processed within 24 h of sampling. To reduce
the risk of mix-up of samples and contamination, sets of
pre-labelled sample collection tubes (containing 60 μL of
aliquoted DNA extraction buffer) and pre-labelled DNA
dilution tubes (containing 300 μL of aliquoted sterile
water) were prepared prior to the start of the study. DNA
extraction and the LAMP assays were performed in separ-
ate areas to avoid contamination. DNA was extracted by
the boil and spin method [10] and 26 μL of the super-
natant was transferred to the DNA dilution tubes. The
LAMP assay was performed with Loopamp™ MALARIA
Pan/Pf Detection Kit (Eiken Chemical Company) as per
protocol [10]. Samples positive for Pan-LAMP were
retested using P. falciparum-LAMP specific kits. LAMP
positive individuals (who were not positive by RDT) were
visited by malaria surveillance officers and provided treat-
ment within 48 h of sampling where possible.
Freezing of samples
Due to a delay in the shipment of LAMP kits, half of the
LAMP samples collected in Unguja (N = 1414) were
stored at −20 °C after DNA extraction and dilution, until
the remaining reaction tubes arrived five weeks later.
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Dilution tubes from LAMP-positive samples in Unguja
were also stored at −20 °C, for quality control of frozen
DNA.
Statistical analysis
Results are reported from individuals for which both
RDT and LAMP were conducted (i.e., where paired data
are available). Statistical analyses were conducted using
Stata/SE 12.1 (StataCorp LP, Texas, USA). The survey de-
sign was taken into consideration when calculating 95 %
confidence intervals (CI 95 %) for prevalence estimations,
using the survey [svy] command in Stata accounting for
household and village sampling/stratification. The sensi-
tivity and specificity of RDT was calculated using LAMP
as the gold standard. McNemar’s test was used to compare
the methods. Statistical significance was determined as
p <0.05.
Results
Study population
Participation was high; informed consent was given by
96.9 % of those present at the time of the survey (Fig. 1).
Both RDT and LAMP results were available for 3983/4085
(97.5 %) of the individuals willing to participate. The
remaining 102 (2.5 %) were excluded from further ana-
lysis. The study population consisted of all ages (median:
18 years, range 0–98), with a higher proportion of females
(59.0 %). Sample collection was conducted during a total
of 19 days with an average of 220 samples processed per
day in the two laboratories combined.
Prevalence of malaria by RDT and LAMP
The prevalence of asymptomatic malaria was 0.5 % (CI
95 % 0.1-0.8) and 1.6 % (CI 95 % 1.1-2.2) by RDT and
Pan-LAMP, respectively (Table 1). Pan-LAMP detected
3.4 (CI 95 % 2.2-5.2) times more Plasmodium positive
samples than RDT. Out of the Pan-LAMP positive sam-
ples 64.6 % (42/65) were also positive by P. falciparum-
LAMP. RDT had a sensitivity of 24.6 % (14.7-36.9) and
specificity of 99.9 % (99.7-100.0) when compared to Pan-
LAMP. Comparison by McNemar’s test showed a signifi-
cant difference between the two methods (p <0.001).
Discrepancies in LAMP after freezing of samples
DNA extracted from half of the samples (N = 1414) in
Unguja was stored at −20 °C prior to LAMP testing due
to a delay in the shipment of LAMP kits. Among these
samples, 32 (2.3 %) were positive by Pan-LAMP, out of
which 12 was also positive by RDT. However, amongst
the frozen samples there were also three RDT positive
samples that were found negative by Pan-LAMP. These
three samples were positive for P. falciparum HRP2
only, Pan-Plasmodium LDH only, and both P. falcip-
arum HRP2 and Pan-Plasmodium LDH, respectively.
Among the samples from Unguja that were screened be-
fore freezing (N = 1370), 11 (0.8 %) were positive by Pan-
LAMP, out of which one was also positive by RDT. The
11 Pan-LAMP positive samples were stored at −20 °C,
as a quality control of freezing DNA, however only 7/11
(63.6 %) were positive when re-tested after thawing.
Fig. 1 Flow chart of study
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LAMP-amplified DNA contamination
During the study DNA contamination of LAMP arose in
the central laboratory in Pemba [see Additional file 1 for
flow chart of events]. The contamination resulted from
using a heat block with a heated pressurized lid during
the 95 °C enzyme inactivation stage, and not allowing
the samples to cool to room temperature before removing
the strips for recording of results. ‘Fizzing’ was observed
around the lid of the LAMP strips resulting in leakage of
LAMP-amplified DNA. All equipment and reagents were
subjected to repetitive decontamination with 5 % sodium
hypochlorite over three days, and moved away from the
epicentre of the contamination to a laboratory space avail-
able in another building. The final enzyme inactivation
step of the protocol [10] was removed as this was thought
to be the source of contamination; instead results were
read and recorded immediately after the amplification re-
action. A negative control was included in each strip of
eight reaction tubes, and any Pan-LAMP positive samples
were repeated and only recorded as positive if positive in
both runs. During the first few days following the contam-
ination there were some samples that were considered
false positive, but the numbers declined and reached zero
within one week after the contamination.
Discussion
This is the hitherto largest reported implementation of
LAMP for detection of asymptomatic malaria in a field
setting. In order to scale-up the breadth of sampling,
LAMP testing was centralized in two laboratories,
meaning samples could be collected from all over the
islands with fewer resources. The time-to-result was ap-
proximately 24 h, compared with three hours in the pilot
study where LAMP was used as a health facility-based,
point-of-care, diagnostic tool for mass screening and
treatment [9].
The results confirm the improved sensitivity of LAMP
over RDT, as has been shown previously [3, 9]. The
MALARIA Pan/Pf Detection Kit has a detection limit of
2–5 parasites/μL [3, 6], for both Pan-Plasmodium and P.
falciparum. This is comparable to PCR, and substantially
lower than the detection limits of P. falciparum-specific
HRP2 (50–100 parasites/μL) and Pan-Plasmodium LDH
(200–500 parasites/μL) in combo RDTs. The proportion
of samples detected only by Pan-LAMP (35.4 %) sug-
gests the presence of species other than P. falciparum.
Similarly, other studies in Zanzibar have shown that up
to 40 % of PCR-detectable malaria infections contained
non-falciparum species [11, 12]. Non-falciparum infec-
tions tend to be of lower parasite densities than P. falcip-
arum infections [13], emphasizing the need for more
sensitive species-specific methods for non-falciparum
Plasmodium detection. The sensitivity (83.8 %) and speci-
ficity (99.7 %) of Pan-LAMP, calculated using PCR as the
reference standard, was high in the pilot study conducted
in Zanzibar [9]. This is similar to previously reported sen-
sitivities and specificities [6–8, 14, 15] and, together with
the results of this study, suggests malaria LAMP is a use-
ful molecular tool sensitive enough for detection of low-
density asymptomatic malaria infections in field settings.
Importantly, some discrepancies were shown amongst
samples screened following freezing of diluted DNA.
RDT false positivity due to recently cleared infections
has been well documented when detecting P. falciparum
HRP2 [16], although none of the three study participants
who were RDT positive/LAMP negative reported receiv-
ing malaria treatment within the previous two weeks,
and two of the RDTs were positive for Pan-Plasmodium
LDH suggesting ongoing infections. The lack of repro-
ducibility of results following freezing of samples sug-
gests that DNA extracted by simple methods such as
boil and spin may not be suitable for long-term storage
and should be amplified by LAMP within a short period
of time [17]. Alternatively, low reproducibility of PCR
for detection of low-density infections has been reported
[18] and parasite densities close to the LAMP detection
limit could also explain the lack of reproducibility.
The potential risk of contamination with LAMP is large,
due to the high efficiency of the reaction, although the risk
is reduced when using a closed system [3, 19]. The MAL-
ARIA Pan/Pf Detection Kit is manufactured with tubes
that cannot be re-opened once closed, in order to avoid
contamination with amplified DNA. However, as demon-
strated in this study, the exposure of such tubes to high
Table 1 Prevalence of malaria detected by RDT and LAMP
RDT LAMP
Overall prevalence (%; CI 95 %a) 0.5; 0.1-0.8 1.6; 1.1-2.2
19/3983 65/3983
Relative proportion positive in:
Only Panb (%; CI 95 %) 5.3; 0.0-16.4 35.4; 23.4-47.4
1/19 23/65
Pan + P. falciparumc (%; CI 95 %) 31.6; 8.5-54.6 64.6; 52.6-76.6
6/19 42/65
Only P. falciparumd (%; CI 95 %) 63.2; 39.2-87.1 NDe
12/19
Both RDT brands used for malaria screening are two-band RDTs detecting
P. falciparum HRP2 and Pan-Plasmodium LDH simultaneously, although with
different detection limits (50–100 parasites/μL for P. falciparum HRP2 and
200–500 parasites/μL for Pan-Plasmodium LDH). In contrast, only the
Pan-LAMP positive samples were assessed for P. falciparum during the LAMP
screening, with a detection limit of 2–5 parasites/μL for both Pan-Plasmodium
and P. falciparum
aConfidence intervals for prevalences were calculated using the survey [svy]
command in Stata, accounting for household and village sampling/stratification
bPositive for Plasmodium genus only
cPositive for Plasmodium and P. falciparum
dPositive for P. falciparum only
eND = not determined
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temperatures, as during enzyme inactivation, results in
softening of the plastic and leakage of the contents. While
removing the inactivation step solved this problem in this
case, contaminations have been experienced in other
research settings [8, 20] and these issues are important to
report. Although MALARIA Pan/Pf Detection Kit is a
field-friendly option, three days’ training is not sufficient
for dealing with such events. Successful decontamination
requires a larger understanding of molecular techniques
and rigorous repetitive methods to ensure that the area is
free of contamination.
Standard malaria diagnostic tools including microscopy
and RDT are not sensitive enough to detect low-density
asymptomatic infections [12]. Nucleic acid amplification-
based methods provide the, to date, most sensitive and ac-
curate tools to detect and identify pathogens [21]. Recently
published, highly sensitive quantitative PCR methods state
detection limits as low as 0.02 and 0.03 parasites/μL
blood [22, 23]. However, these methods lack the field
applicability that LAMP offers. Furthermore, the cost
of LAMP is estimated to be a tenth of that of conven-
tional PCR [15], although the cost of the field friendly
kit is still at 5.3 US$ per reaction i.e., considerably more
expensive than RDTs [3].
The high cost and risk of contamination may yet limit
the implementation LAMP at a point-of-care level, but
LAMP will be valuable for research purposes and for
evaluating malaria elimination efforts. LAMP may, for ex-
ample, be useful in mass/focal screening and treatment
(MSAT/FSAT) programmes, for which the deployment of
RDTs, perhaps due to their low sensitivity, has had varying
results [11, 24]. In any case it will be important to evaluate
the impact and cost effectiveness of deploying LAMP, in
comparison to the deployment of standard diagnostic tools
as well as in comparison to alternative molecular methods.
Conclusions
LAMP is a simple and sensitive molecular tool, and has
potential in active surveillance and mass-screening pro-
grammes for detection of low-density asymptomatic mal-
aria in pre-elimination settings. However, in order to
deploy LAMP more effectively in field settings, protocols
may need to be adapted for processing larger numbers of
samples. A higher throughput, affordable closed system
would be ideal to avoid contamination.
Additional file
Additional file 1: Flow chart of events that took place during LAMP
DNA contamination and decontamination. A figure showing the flow
of events that took place during a DNA contamination when screening
for asymptomatic malaria by LAMP in Zanzibar The flow chart shows
how the DNA contamination was resolved by repetitive decontamination
of all equipment with 5 % sodium hypochlorite and moving away from
the site of contamination.
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